.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
Johnson and Johnson
US Department of Justice
QuintilesIMS
Cantor Fitzgerald
Novartis
Teva
US Army
Boehringer Ingelheim

Generated: July 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078371

« Back to Dashboard
NDA 078371 describes FINASTERIDE, which is a drug marketed by Zydus Pharms Usa Inc, Alkem Labs Ltd, Teva, Sun Pharma Global, Actavis Totowa Teva, Accord Hlthcare, Cipla Ltd, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Aurobindo Pharma, Gedeon Richter Usa, Hetero Labs Ltd Iii, Mylan Pharms Inc, Actavis Totowa, Mylan, and Aurobindo Pharma Ltd, and is included in twenty-two NDAs. It is available from forty suppliers. Additional details are available on the FINASTERIDE profile page.

The generic ingredient in FINASTERIDE is finasteride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Summary for NDA: 078371

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Genitourinary Agents
Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Pharmacology for NDA: 078371

Mechanism of Action5-alpha Reductase Inhibitors

Suppliers and Packaging for NDA: 078371

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FINASTERIDE
finasteride
TABLET;ORAL 078371 ANDA Actavis Pharma, Inc. 45963-600 45963-600-03 30 TABLET, FILM COATED in 1 BOTTLE (45963-600-03)
FINASTERIDE
finasteride
TABLET;ORAL 078371 ANDA Actavis Pharma, Inc. 45963-600 45963-600-09 90 TABLET, FILM COATED in 1 BOTTLE (45963-600-09)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Nov 5, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Citi
Covington
Chinese Patent Office
Mallinckrodt
Teva
Cantor Fitzgerald
Harvard Business School
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot